GLEEVEC-D8 Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Yellow Solid

Verwenden

A deuterated tyrosine kinase inhibitor. Highly specific for BCR-ABL, the enzyme associated with chronic myelogenous leukemia (CML) and certain forms of acute lymphoblastic leukemia (ALL)

GLEEVEC-D8 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

GLEEVEC-D8 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
3B Pharmachem (Wuhan) International Co.,Ltd.	821-50328103-801 18930552037	3bsc@sina.com	China	15839	69
Chemsky（shanghai）International Co.,Ltd.	021-50135380	shchemsky@sina.com	China	32321	50
Wuxi Minglu Medicine technology Co.,Ltd.	0510-88726693	3204601684@qq.com	China	2215	58

---

• STI-571-D8
• CGP-57148BETA-D8
• GLIVEC-D8
• GLEEVEC-D8
• IMATINIBETA-D8 METHANESULFONATE
• Imatinib-d8 Methanesulfonate, STI-571-d8, CGP-57148B-d8, Glivec-d8,
• (matinib-D8 Methanesulfonate, STI-571-D8, CGP-57148B-D8, Glivec-D8)
• 4-[(4-Methyl-1-piperazinyl-d8)Methyl]-N-[4-Methyl-3-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]phenyl]benzaMide Methanesulfonate
• CGP 57148B-d8
• Gleevac-d8
• Gleevec-d8 Mesylate (IMatinib-d8 Mesylate)
• IMatinib-d8 Mesilate
• IMatinib-d8 Mesylate
• C30H27D8N7O4S
• C29H23N7OD8
• Intermediates & Fine Chemicals
• Isotope Labeled Compounds
• Pharmaceuticals
• Tyrosine Kinase Inhibitors